Patients taking benralizumab, dupilumab, or mepolizumab have lower postvaccination SARS-CoV-2 immunity
接受贝那利珠单抗、度普利尤单抗或美泊利珠单抗治疗的患者，接种SARS-CoV-2疫苗后的免疫力较低。
期刊:Journal of Allergy and Clinical Immunology
影响因子:11.2
doi:10.1016/j.jaci.2024.03.029
Runnstrom, Martin C; Lamothe, Pedro A; Faliti, Caterina E; Cheedarla, Narayanaiah; Moreno, Alberto; Suthar, Mehul S; Nahata, Rishika; Ravindran, Mayuran; Haddad, Natalie S; Morrison-Porter, Andrea; Quehl, Hannah; Ramonell, Richard P; Woodruff, Matthew; Anam, Fabliha; Zhang, Rebeca; Swenson, Colin; Polito, Carmen; Neveu, Wendy; Patel, Rahulkumar; Smirnova, Natalia; Nguyen, Doan C; Kim, Caroline; Hentenaar, Ian; Kyu, Shuya; Usman, Sabeena; Ngo, Thuy; Guo, Zhenxing; Wu, Hao; Daiss, John L; Park, Jiwon; Manning, Kelly E; Wali, Bursha; Ellis, Madison L; Sharma, Sunita; Holguin, Fernando; Cheedarla, Suneethamma; Neish, Andrew S; Roback, John D; Sanz, Ignacio; Eun-Hyung Lee, F
